Literature DB >> 16254350

Alpha/beta interferons regulate murine gammaherpesvirus latent gene expression and reactivation from latency.

Erik S Barton1, Mary L Lutzke, Rosemary Rochford, Herbert W Virgin.   

Abstract

Alpha/beta interferon (IFN-alpha/beta) protects the host from virus infection by inhibition of lytic virus replication in infected cells and modulation of the antiviral cell-mediated immune response. To determine whether IFN-alpha/beta also modulates the virus-host interaction during latent virus infection, we infected mice lacking the IFN-alpha/beta receptor (IFN-alpha/betaR(-/-)) and wild-type (wt; 129S2/SvPas) mice with murine gammaherpesvirus 68 (gammaHV68), a lymphotropic gamma-2-herpesvirus that establishes latent infection in B cells, macrophages, and dendritic cells. IFN-alpha/betaR(-/-) mice cleared low-dose intranasal gammaHV68 infection with wt kinetics and harbored essentially wt frequencies of latently infected cells in both peritoneum and spleen by 28 days postinfection. However, latent virus in peritoneal cells and splenocytes from IFN-alpha/betaR(-/-) mice reactivated ex vivo with >40-fold- and 5-fold-enhanced efficiency, respectively, compared to wt cells. Depletion of IFN-alpha/beta from wt mice during viral latency also significantly increased viral reactivation, demonstrating an antiviral function of IFN-alpha/beta during latency. Viral reactivation efficiency was temporally regulated in both wt and IFN-alpha/betaR(-/-) mice. The mechanism of IFN-alpha/betaR action was distinct from that of IFN-gammaR, since IFN-alpha/betaR(-/-) mice did not display persistent virus replication in vivo. Analysis of viral latent gene expression in vivo demonstrated specific upregulation of the latency-associated gene M2, which is required for efficient reactivation from latency, in IFN-alpha/betaR(-/-) splenocytes. These data demonstrate that an IFN-alpha/beta-induced pathway regulates gammaHV68 gene expression patterns during latent viral infection in vivo and that IFN-alpha/beta plays a critical role in inhibiting viral reactivation during latency.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16254350      PMCID: PMC1280204          DOI: 10.1128/JVI.79.22.14149-14160.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  104 in total

1.  Effects of PKR/RNase L-dependent and alternative antiviral pathways on alphavirus replication and pathogenesis.

Authors:  Kate D Ryman; Laura J White; Robert E Johnston; William B Klimstra
Journal:  Viral Immunol       Date:  2002       Impact factor: 2.257

Review 2.  Interferon regulatory factor 7: a key cellular mediator of LMP-1 in EBV latency and transformation.

Authors:  L Zhang; J S Pagano
Journal:  Semin Cancer Biol       Date:  2001-12       Impact factor: 15.707

3.  Complete sequence and genomic analysis of murine gammaherpesvirus 68.

Authors:  H W Virgin; P Latreille; P Wamsley; K Hallsworth; K E Weck; A J Dal Canto; S H Speck
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

4.  IRF-7, a new interferon regulatory factor associated with Epstein-Barr virus latency.

Authors:  L Zhang; J S Pagano
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

Review 5.  On the role of IRF in host defense.

Authors:  Betsy Barnes; Barbora Lubyova; Paula M Pitha
Journal:  J Interferon Cytokine Res       Date:  2002-01       Impact factor: 2.607

6.  Disruption of the M2 gene of murine gammaherpesvirus 68 alters splenic latency following intranasal, but not intraperitoneal, inoculation.

Authors:  Meagan A Jacoby; Herbert W Virgin; Samuel H Speck
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

Review 7.  Activation and inhibition of virus and interferon: the herpesvirus story.

Authors:  Karen L Mossman
Journal:  Viral Immunol       Date:  2002       Impact factor: 2.257

8.  A Kaposi's sarcoma-associated herpesviral protein inhibits virus-mediated induction of type I interferon by blocking IRF-7 phosphorylation and nuclear accumulation.

Authors:  Fan Xiu Zhu; Sonya M King; Eric J Smith; David E Levy; Yan Yuan
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-09       Impact factor: 11.205

9.  Antibody-mediated control of persistent gamma-herpesvirus infection.

Authors:  In-Jeong Kim; Emilio Flaño; David L Woodland; Marcia A Blackman
Journal:  J Immunol       Date:  2002-04-15       Impact factor: 5.422

10.  KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway.

Authors:  S J Gao; C Boshoff; S Jayachandra; R A Weiss; Y Chang; P S Moore
Journal:  Oncogene       Date:  1997-10-16       Impact factor: 9.867

View more
  52 in total

1.  Virally-induced upregulation of heparan sulfate on B cells via the action of type I IFN.

Authors:  Nadine Jarousse; Damian L Trujillo; Sarah Wilcox-Adelman; Laurent Coscoy
Journal:  J Immunol       Date:  2011-11-02       Impact factor: 5.422

2.  Tiled microarray identification of novel viral transcript structures and distinct transcriptional profiles during two modes of productive murine gammaherpesvirus 68 infection.

Authors:  Benson Yee Hin Cheng; Jizu Zhi; Alexis Santana; Sohail Khan; Eduardo Salinas; J Craig Forrest; Yueting Zheng; Shirin Jaggi; Janet Leatherwood; Laurie T Krug
Journal:  J Virol       Date:  2012-02-08       Impact factor: 5.103

3.  CD4 T-cell help programs a change in CD8 T-cell function enabling effective long-term control of murine gammaherpesvirus 68: role of PD-1-PD-L1 interactions.

Authors:  Peter Dias; Francesca Giannoni; Lian Ni Lee; Dongun Han; Sorah Yoon; Hideo Yagita; Miyuki Azuma; Sally R Sarawar
Journal:  J Virol       Date:  2010-06-09       Impact factor: 5.103

Review 4.  When autophagy meets viruses: a double-edged sword with functions in defense and offense.

Authors:  Hee Jin Kim; Stacy Lee; Jae U Jung
Journal:  Semin Immunopathol       Date:  2010-09-25       Impact factor: 9.623

5.  Inhibition of RIG-I-mediated signaling by Kaposi's sarcoma-associated herpesvirus-encoded deubiquitinase ORF64.

Authors:  Kyung-Soo Inn; Sun-Hwa Lee; Jessica Y Rathbun; Lai-Yee Wong; Zsolt Toth; Keigo Machida; Jing-Hsiung James Ou; Jae U Jung
Journal:  J Virol       Date:  2011-08-10       Impact factor: 5.103

6.  Type I Interferon Counteracts Antiviral Effects of Statins in the Context of Gammaherpesvirus Infection.

Authors:  Philip T Lange; Eric J Darrah; Emily P Vonderhaar; Wadzanai P Mboko; Michaela M Rekow; Shailendra B Patel; Duska J Sidjanin; Vera L Tarakanova
Journal:  J Virol       Date:  2016-01-06       Impact factor: 5.103

7.  Cytoplasmic isoforms of Kaposi sarcoma herpesvirus LANA recruit and antagonize the innate immune DNA sensor cGAS.

Authors:  Guigen Zhang; Baca Chan; Naira Samarina; Bizunesh Abere; Magdalena Weidner-Glunde; Anna Buch; Andreas Pich; Melanie M Brinkmann; Thomas F Schulz
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-25       Impact factor: 11.205

8.  Latent virus infection upregulates CD40 expression facilitating enhanced autoimmunity in a model of multiple sclerosis.

Authors:  Costanza Casiraghi; Ana Citlali Márquez; Iryna Shanina; Marc Steven Horwitz
Journal:  Sci Rep       Date:  2015-09-10       Impact factor: 4.379

9.  LXR Alpha Restricts Gammaherpesvirus Reactivation from Latently Infected Peritoneal Cells.

Authors:  P T Lange; C N Jondle; E J Darrah; K E Johnson; V L Tarakanova
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

10.  Type I interferons link viral infection to enhanced epithelial turnover and repair.

Authors:  Lulu Sun; Hiroyuki Miyoshi; Sofia Origanti; Timothy J Nice; Alexandra C Barger; Nicholas A Manieri; Leslie A Fogel; Anthony R French; David Piwnica-Worms; Helen Piwnica-Worms; Herbert W Virgin; Deborah J Lenschow; Thaddeus S Stappenbeck
Journal:  Cell Host Microbe       Date:  2014-12-04       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.